{"id":167669,"date":"2023-07-16T20:22:46","date_gmt":"2023-07-17T01:22:46","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/07\/alzheimers-diagnosis-revamp-embraces-rating-scale-similar-to-cancer"},"modified":"2023-07-16T20:22:46","modified_gmt":"2023-07-17T01:22:46","slug":"alzheimers-diagnosis-revamp-embraces-rating-scale-similar-to-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/07\/alzheimers-diagnosis-revamp-embraces-rating-scale-similar-to-cancer","title":{"rendered":"Alzheimer\u2019s diagnosis revamp embraces rating scale similar to cancer"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/alzheimers-diagnosis-revamp-embraces-rating-scale-similar-to-cancer2.jpg\"><\/a><\/p>\n<p>July 16 (Reuters) \u2014 Alzheimer\u2019s disease experts are revamping the way doctors diagnose patients with the progressive brain disorder \u2014 the most common type of dementia \u2014 by devising a seven-point rating scale based on cognitive and biological changes in the patient.<\/p>\n<p>The proposed guidelines, unveiled by experts on Sunday in a report issued at an Alzheimer\u2019s Association conference in Amsterdam, embrace a numerical staging system assessing disease progression similar to the one used in cancer diagnoses. They also eliminate the use of terms like mild, moderate and severe.<\/p>\n<p>The revamp \u2014 replacing guidelines issued in 2018 \u2014 was prompted by the increased availability of tests detecting key Alzheimer\u2019s-related proteins such as beta amyloid in the blood and new treatments that require confirmation of disease pathology prior to use.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>July 16 (Reuters) \u2014 Alzheimer\u2019s disease experts are revamping the way doctors diagnose patients with the progressive brain disorder \u2014 the most common type of dementia \u2014 by devising a seven-point rating scale based on cognitive and biological changes in the patient. The proposed guidelines, unveiled by experts on Sunday in a report issued at [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-167669","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/167669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=167669"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/167669\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=167669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=167669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=167669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}